Cargando…
Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing public health emergency. The pathogenesis and complications advanced with infection mainly involve immune-inflammatory cascade. Therefore, the therapeutic strategy relie...
Autores principales: | Nagoor Meeran, M.F., Javed, Hayate, Sharma, Charu, Goyal, Sameer N., Kumar, Sanjay, Jha, Niraj Kumar, Ojha, Shreesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870107/ https://www.ncbi.nlm.nih.gov/pubmed/33585706 http://dx.doi.org/10.1016/j.heliyon.2021.e05990 |
Ejemplares similares
-
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
por: Jha, Niraj Kumar, et al.
Publicado: (2021) -
Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
por: Nagoor Meeran, M.F., et al.
Publicado: (2020) -
Carvacrol, a Plant Metabolite Targeting Viral Protease (M(pro)) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19
por: Javed, Hayate, et al.
Publicado: (2021) -
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023) -
Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19
por: Sharma, Charu, et al.
Publicado: (2021)